Ieq Capital LLC bought a new position in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 799,214 shares of the company’s stock, valued at approximately $102,699,000. Ieq Capital LLC owned approximately 0.62% of Merck KGaA as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Frazier Financial Advisors LLC acquired a new position in shares of Merck KGaA in the second quarter worth $25,000. Kilter Group LLC acquired a new stake in shares of Merck KGaA in the second quarter valued at $62,000. Addison Advisors LLC purchased a new position in Merck KGaA in the second quarter valued at $90,000. Hara Capital LLC purchased a new position in Merck KGaA in the second quarter valued at $110,000. Finally, Comprehensive Financial Planning Inc. PA acquired a new position in Merck KGaA during the 2nd quarter worth $134,000. Hedge funds and other institutional investors own 0.10% of the company’s stock.
Merck KGaA Price Performance
Shares of OTCMKTS MKGAF opened at $163.21 on Friday. The stock’s 50-day moving average is $162.62 and its two-hundred day moving average is $148.46. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. Merck KGaA has a 1-year low of $116.68 and a 1-year high of $175.56. The company has a market cap of $21.09 billion, a price-to-earnings ratio of 24.92 and a beta of 0.96.
Merck KGaA Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Further Reading
- Five stocks we like better than Merck KGaA
- Blueprint for a Boom: SEC Clears the Crypto Runway
- Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss
- Advance Auto Parts Plunged, But Its Turnaround Is Still Working
- Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
